Financial reports
10-Q
2024 Q1
Quarterly report
14 Feb 24
10-K
2023 FY
Annual report
14 Dec 23
10-Q
2023 Q3
Quarterly report
14 Aug 23
ARS
2022 FY
Annual report to shareholders
7 Aug 23
10-Q
2023 Q2
Quarterly report
10 May 23
10-Q
2023 Q1
Quarterly report
13 Feb 23
10-K
2022 FY
Annual report
15 Dec 22
10-Q
2022 Q3
Quarterly report
15 Aug 22
10-Q
2022 Q2
Quarterly report
10 May 22
10-Q
2022 Q1
Quarterly report
8 Feb 22
Current reports
8-K
Regulation FD Disclosure
11 Mar 24
8-K
Other Events
6 Mar 24
8-K
Sonnet BioTherapeutics Provides Fiscal Year 2024 First Quarter Business and Earnings Update
14 Feb 24
8-K
Other Events
1 Feb 24
8-K
Other Events
29 Jan 24
8-K
Departure of Directors or Certain Officers
27 Dec 23
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
15 Dec 23
8-K
Sonnet BioTherapeutics Provides Fiscal Year 2023 Business and Financial Update
14 Dec 23
8-K
Other Events
19 Sep 23
8-K
Material Modifications to Rights of Security Holders
1 Sep 23
Registration and prospectus
S-3
Shelf registration
22 Dec 23
424B4
Prospectus supplement with pricing info
26 Oct 23
S-1/A
IPO registration (amended)
19 Oct 23
S-1/A
IPO registration (amended)
4 Oct 23
S-1/A
IPO registration (amended)
28 Sep 23
S-1
IPO registration
19 Sep 23
S-8
Registration of securities for employees
21 Aug 23
424B4
Prospectus supplement with pricing info
9 Aug 23
S-1
IPO registration
28 Jul 23
D
$2.25 mm in equity / options / securities to be acquired, sold $2.25 mm, 1 investor
17 Jul 23
Proxies
DEFA14A
Additional proxy soliciting materials
22 Aug 23
DEF 14A
Definitive proxy
7 Aug 23
PRE 14A
Preliminary proxy
28 Jul 23
DEF 14A
Definitive proxy
25 Aug 22
PRE 14A
Preliminary proxy
15 Aug 22
DEFA14A
Additional proxy soliciting materials
3 Jun 22
DEFA14A
Additional proxy soliciting materials
2 Jun 22
DEFA14A
Additional proxy soliciting materials
13 Apr 22
DEFA14A
Additional proxy soliciting materials
11 Apr 22
DEF 14A
Definitive proxy
11 Apr 22
Other
EFFECT
Notice of effectiveness
5 Jan 24
CORRESP
Correspondence with SEC
3 Jan 24
UPLOAD
Letter from SEC
29 Dec 23
EFFECT
Notice of effectiveness
25 Oct 23
CORRESP
Correspondence with SEC
23 Oct 23
CORRESP
Correspondence with SEC
23 Oct 23
CORRESP
Correspondence with SEC
28 Sep 23
CORRESP
Correspondence with SEC
28 Sep 23
CORRESP
Correspondence with SEC
28 Sep 23
CORRESP
Correspondence with SEC
28 Sep 23